ROQUEFORT THERAPEUTICS PLC
ISIN: GB00BMDQ2T15 | LEI: 254900P4SISIWOR9RH34
Country: United Kingdom
Eccleston Yards, 25 Eccleston Place, SW1W 9NF London – United Kingdom
| Line item in (gbp) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Current Trade Receivables | N/A | 15,123.00 | 26,430.00 |
| Cash and cash equivalents | 16,002.00 | 8,198.00 | 35,567.00 |
| Reserve Of Sharebased Payments | N/A | -713,857.00 | -643,122.00 |
| Merger Reserve | N/A | N/A | 3,700,000.00 |
| Current Accrued Expenses And Other Current Liabilities | N/A | 429,255.00 | 480,213.00 |
| Line item in (gbp) | 01.01.2021/ 01.01.2022 |
17.08.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Profit (loss) | -1,033,713.00 | -917,433.00 | -179,569.00 |
| Line item in (gbp) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | N/A | -917,433.00 | -179,569.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 3,082.00 | 176,357.00 |
| Cash and cash equivalents | 16,002.00 | 8,198.00 | 35,567.00 |
Please note that some sums might not add up.
GB00BMDQ2T15
LEI254900P4SISIWOR9RH34
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.